T-cell Developmental Status in Patients With Malignant Hematological Tumors

RecruitingOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

June 22, 2025

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions
Hematologic Malignancy
Interventions
OTHER

observational study

observational study

Trial Locations (1)

361000

RECRUITING

Zhijuan Lin, Xiamen

All Listed Sponsors
lead

The First Affiliated Hospital of Xiamen University

OTHER

NCT07035938 - T-cell Developmental Status in Patients With Malignant Hematological Tumors | Biotech Hunter | Biotech Hunter